"Epoetin Alfa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
| Descriptor ID |
D000068817
|
| MeSH Number(s) |
D12.644.276.374.410.240.150.500 D12.776.395.240.150.750 D12.776.467.374.410.240.150.500 D23.529.374.410.240.150.750
|
| Concept/Terms |
Epoetin Alfa- Epoetin Alfa
- Alfa, Epoetin
- Recombinant 1-165 Erythropoietin, Glycoform Alpha
- Recombinant 1 165 Erythropoietin, Glycoform Alpha
|
Below are MeSH descriptors whose meaning is more general than "Epoetin Alfa".
Below are MeSH descriptors whose meaning is more specific than "Epoetin Alfa".
This graph shows the total number of publications written about "Epoetin Alfa" by people in this website by year, and whether "Epoetin Alfa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epoetin Alfa" by people in Profiles.
-
Hill JW, Shreay S, McGarvey N, De AP, Hess GP, Corey-Lisle PK. Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits. Support Care Cancer. 2013 Nov; 21(11):2957-65.
-
Pizzi LT, Bunz TJ, Coyne DW, Goldfarb DS, Singh AK. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int. 2008 Dec; 74(12):1588-95.
-
Spinowitz B, Germain M, Benz R, Wolfson M, McGowan T, Tang KL, Kamin M. A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul; 3(4):1015-21.
-
Jaspan D. Erythropoietic therapy: cost efficiency and reimbursement. Am J Health Syst Pharm. 2007 Aug 15; 64(16 Suppl 11):S19-29.
-
Benz R, Schmidt R, Kelly K, Wolfson M. Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease. Clin J Am Soc Nephrol. 2007 Mar; 2(2):215-21.
-
Ackerman BH, Reilly KJ, Guilday RE, Patton ML, Haith LR. Quality assurance assessment of the use of linezolid in the treatment of thermal injury patients at a community teaching hospital. J Burn Care Res. 2007 Jan-Feb; 28(1):145-51.
-
ERSLEV AJ, SOLIT RW, CAMISHION RC, AMSEL S, ILDA J, BALLINGER WF. ERYTHROPOIETIN IN VITRO. 3. PERFUSION OF A LUNG-KIDNEY PREPARATION. Am J Physiol. 1965 Jun; 208:1153-7.